Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects
NCT04488900
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
88
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
CKD-508 Capsule
DRUG:
Placebo Capsule
DRUG:
CKD-508 Tablet
DRUG:
Placebo Tablet
Sponsor
Chong Kun Dang Pharmaceutical